These medications work by reducing hunger, slowing stomach emptying, and altering food preferences, which can lead to lower calorie intake and, in some cases, unintended side effects such as nausea, constipation, and loss of lean muscle mass
When administered in this manner, GHK-Cu appears to be non-toxic and non-irritating with no adverse effects [2]
For instance, semaglutide can cause: Nausea and other gastrointestinal discomfort
I think NPs just look at the whole person
The SURPASS trial (NCT04093752) will compare tirzepatide with liraglutide in high-risk patients with T2DM, while the SURMOUNT MMO study (NCT05556512) will evaluate the impact of tirzepatide on morbidity and mortality in patients with obesity
The area covered and the technique adopted by your surgeon play a major role in the results as well as how long they last